Cargando…

Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia

The issue of delayed neurological damage as a result of treatment is becoming increasingly important now that an increased number of children survive treatment for acute lymphoblastic leukemia (ALL). Following modification of the treatment protocols, severe symptomatic late effects are rare, and mos...

Descripción completa

Detalles Bibliográficos
Autores principales: BADR, MOHAMED AHMED, HASSAN, TAMER HASAN, EL-GERBY, KHALED MOHAMED, LAMEY, MOHAMED EL-SAYED
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573121/
https://www.ncbi.nlm.nih.gov/pubmed/23420690
http://dx.doi.org/10.3892/ol.2012.1072
_version_ 1782259409083170816
author BADR, MOHAMED AHMED
HASSAN, TAMER HASAN
EL-GERBY, KHALED MOHAMED
LAMEY, MOHAMED EL-SAYED
author_facet BADR, MOHAMED AHMED
HASSAN, TAMER HASAN
EL-GERBY, KHALED MOHAMED
LAMEY, MOHAMED EL-SAYED
author_sort BADR, MOHAMED AHMED
collection PubMed
description The issue of delayed neurological damage as a result of treatment is becoming increasingly important now that an increased number of children survive treatment for acute lymphoblastic leukemia (ALL). Following modification of the treatment protocols, severe symptomatic late effects are rare, and most adverse effects are detected by sensitive imaging methods such as magnetic resonance imaging (MRI) or by neuropsychological testing. In this study we aimed to determine the prevalence and characteristics of late central nervous system (CNS) damage by MRI and clinical examination in children treated for ALL. A cross-sectional study was carried out at the pediatric oncology unit of Zagazig University, Egypt, and included 25 patients who were consecutively enrolled and treated according to the modified Children’s Cancer Group (CCG) 1991 protocol for standard risk ALL and the modified CCG 1961 protocol for high-risk ALL and who had survived more than 5 years from the diagnosis. All relevant data were collected from patients’ medical records; particularly the data concerning the initial clinical presentation and initial brain imaging. All patients were subjected to thorough history and full physical examination with special emphasis on the neurological system. MRI of the brain was performed for all patients. The mean age of patients was 6.9±3.04 years at diagnosis and was 12.9±3.2 years at the time of study. The patients comprised 14 boys and 11 girls. Abnormal MRI findings were detected in six patients (24%). They were in the form of leukoencephalopathy in two patients (8%), brain atrophy in two patients (8%), old infarct in one patient (4%) and old hemorrhage in one patient (4%). The number of abnormal MRI findings was significantly higher in high-risk patients, patients who had CNS manifestations at diagnosis and patients who had received cranial irradiation. We concluded that cranial irradiation is associated with higher incidence of MRI changes in children treated for ALL. Limitation of cranial irradiation to selected patients contributed to a lower incidence of neurological complications in our study. MRI is a sensitive radiological tool to detect structural changes in children treated for ALL, even in asymptomatic cases.
format Online
Article
Text
id pubmed-3573121
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-35731212013-02-15 Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia BADR, MOHAMED AHMED HASSAN, TAMER HASAN EL-GERBY, KHALED MOHAMED LAMEY, MOHAMED EL-SAYED Oncol Lett Articles The issue of delayed neurological damage as a result of treatment is becoming increasingly important now that an increased number of children survive treatment for acute lymphoblastic leukemia (ALL). Following modification of the treatment protocols, severe symptomatic late effects are rare, and most adverse effects are detected by sensitive imaging methods such as magnetic resonance imaging (MRI) or by neuropsychological testing. In this study we aimed to determine the prevalence and characteristics of late central nervous system (CNS) damage by MRI and clinical examination in children treated for ALL. A cross-sectional study was carried out at the pediatric oncology unit of Zagazig University, Egypt, and included 25 patients who were consecutively enrolled and treated according to the modified Children’s Cancer Group (CCG) 1991 protocol for standard risk ALL and the modified CCG 1961 protocol for high-risk ALL and who had survived more than 5 years from the diagnosis. All relevant data were collected from patients’ medical records; particularly the data concerning the initial clinical presentation and initial brain imaging. All patients were subjected to thorough history and full physical examination with special emphasis on the neurological system. MRI of the brain was performed for all patients. The mean age of patients was 6.9±3.04 years at diagnosis and was 12.9±3.2 years at the time of study. The patients comprised 14 boys and 11 girls. Abnormal MRI findings were detected in six patients (24%). They were in the form of leukoencephalopathy in two patients (8%), brain atrophy in two patients (8%), old infarct in one patient (4%) and old hemorrhage in one patient (4%). The number of abnormal MRI findings was significantly higher in high-risk patients, patients who had CNS manifestations at diagnosis and patients who had received cranial irradiation. We concluded that cranial irradiation is associated with higher incidence of MRI changes in children treated for ALL. Limitation of cranial irradiation to selected patients contributed to a lower incidence of neurological complications in our study. MRI is a sensitive radiological tool to detect structural changes in children treated for ALL, even in asymptomatic cases. D.A. Spandidos 2013-02 2012-12-12 /pmc/articles/PMC3573121/ /pubmed/23420690 http://dx.doi.org/10.3892/ol.2012.1072 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
BADR, MOHAMED AHMED
HASSAN, TAMER HASAN
EL-GERBY, KHALED MOHAMED
LAMEY, MOHAMED EL-SAYED
Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title_full Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title_fullStr Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title_full_unstemmed Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title_short Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
title_sort magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573121/
https://www.ncbi.nlm.nih.gov/pubmed/23420690
http://dx.doi.org/10.3892/ol.2012.1072
work_keys_str_mv AT badrmohamedahmed magneticresonanceimagingofthebraininsurvivorsofchildhoodacutelymphoblasticleukemia
AT hassantamerhasan magneticresonanceimagingofthebraininsurvivorsofchildhoodacutelymphoblasticleukemia
AT elgerbykhaledmohamed magneticresonanceimagingofthebraininsurvivorsofchildhoodacutelymphoblasticleukemia
AT lameymohamedelsayed magneticresonanceimagingofthebraininsurvivorsofchildhoodacutelymphoblasticleukemia